Advanced NSCLC Patients at the Extremes of Age in the Era of EGFR-TKIs

被引：0
|
作者：
Chen, Yu-Mu [1 ]
Lai, Chien-Hao [2 ]
Chang, Huang-Chih [3 ]
Chao, Tung-Ying [3 ]
Tseng, Chia-Cheng [2 ]
Fang, Wen-Feng [2 ]
Chung, Yu-Hsiu [2 ]
Wang, Yi-Hsi [2 ]
Su, Mao-Chang [2 ]
Huang, Kuo-Tung [2 ]
Wang, Chin-Chou [2 ]
Lin, Meng-Chih [2 ]
机构：
[1] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
[2] Chang Gung Mem Hosp Kaohsiung, Kaohsiung, Taiwan
[3] Kaohsiung Chang Gung Mem Hosp, Pulmonary & Crit Care Med, Kaohsiung, Taiwan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Extreme age; non-small cell lung cancer; Tyrosine kinase inhibitors;
D O I：
10.1016/j.jtho.2016.11.1971
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PUB001
引用
收藏
页码：S1445 / S1445
页数：1
相关论文
共 50 条
  • [21] Bisphosphonates Enhance Effect of EGFR-TKIs in NSCLC Patients with EGFR Mutation and Bone Metastases
    Jiang, Tao
    Zhou, Caicun
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1236 - S1236
  • [22] Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patients
    Xiong, Liwen
    Cui, Shaohua
    Ding, Jingyan
    Sun, Yun
    Zhang, Longfu
    Zhao, Yizhuo
    Gu, Aiqin
    Chu, Tianqing
    Wang, Huimin
    Zhong, Hua
    Ye, Xin
    Gu, Yi
    Zhang, Xin
    Hu, Min
    Jiang, Liyan
    [J]. ONCOTARGET, 2017, 8 (38) : 63846 - 63856
  • [23] The Predictive Value of Longitudinal Monitoring of Mutated EGFR in Plasma of Advanced NSCLC Patients on First-Line EGFR-TKIs
    Szpechcinski, A.
    Bryl, M.
    Wojda, E.
    Czyzewicz, G.
    Swiniuch, D.
    Szwiec, M.
    Ramlau, R.
    Sliwinski, P.
    Barinow-Wojewodzki, A.
    Chorostowska-Wynimko, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S434 - S435
  • [24] EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in EGFR-mutant NSCLC patients with multiple brain metastases
    Jiang, T.
    Zhou, C.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [25] EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in patients with EGFR-mutant NSCLC and multiple brain metastases
    Jiang, Tao
    Zhang, Yongchang
    Li, Xuefei
    Zhao, Chao
    Chen, Xiaoxia
    Su, Chunxia
    Ren, Shengxiang
    Yang, Nong
    Zhou, Caicun
    [J]. EUROPEAN JOURNAL OF CANCER, 2019, 121 : 98 - 108
  • [26] Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs
    Sheng, Jin
    Zhang, Li
    Yang, Yunpeng
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S230 - S230
  • [27] Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs
    Sheng, Jin
    Yang, Yun-Peng
    Ma, Yu-Xiang
    Qin, Tao
    Hu, Zhi-Huang
    Hong, Shao-Dong
    Zhou, Ting
    Huang, Yan
    Zhao, Hong-Yun
    Zhang, Li
    [J]. PLOS ONE, 2016, 11 (01):
  • [28] COMPARISON OF COST-EFFECTIVENESS BETWEEN EGFR-TKIS THERAPY AND CHEMOTHERAPY FOR ADVANCED NSCLC
    Zhang, T.
    Cai, S.
    Wu, C.
    Xu, J.
    Lin, T.
    Jiang, J.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A887 - A887
  • [29] A Randomized Study of Concurrent vs Sequential Alternating EGFR-TKIs and Chemotherapy for Advanced NSCLC with EGFR Mutations
    Yong, H.
    Hui, L.
    Fang, L.
    Dong, L.
    Ling, X.
    Qiang, W.
    Peng, X.
    Hua, H.
    Yang, Y.
    Ping, G.
    Cui, K.
    Wu, W.
    Yu, C.
    Huo, L.
    Qiang, X.
    Xi, S.
    Jin, C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S592 - S593
  • [30] Impacts of EGFR mutation and EGFR-TKIs on incidence of brain metastases in advanced non-squamous NSCLC
    Wang, Bao-Xiao
    Ou, Wei
    Mao, Xiao-Yong
    Liu, Zui
    Wu, Hui-Qi
    Wang, Si-Yu
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2017, 160 : 96 - 100
12345